Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) lacks reliable serological biomarkers for predicting patients' survival and response to treatment. The present study examined the capability of serum LAMC2 and four known tumour markers for disease prognosis and patients' risk stratification....

Descripción completa

Detalles Bibliográficos
Autores principales: Korbakis, D, Dimitromanolakis, A, Prassas, I, Davis, G J, Barber, E, Reckamp, K L, Blasutig, I, Diamandis, E P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522621/
https://www.ncbi.nlm.nih.gov/pubmed/26180921
http://dx.doi.org/10.1038/bjc.2015.171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522621/
https://www.ncbi.nlm.nih.gov/pubmed/26180921
http://dx.doi.org/10.1038/bjc.2015.171

Ejemplares similares